Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zenabis Global Inc. T.ZENA

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space.


TSX:ZENA - Post by User

Zenabis Global Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(31)
•••
Post by skythelimiton Dec 03, 2019 1:33pm
138 Views
Post# 30417984

Fair Value 56 cents From Morningstar equity research

Fair Value 56 cents From Morningstar equity researchZenabis Global Inc ZENA QQQ 28 Nov 2019, 23:25 UTC Economic Moat Uncertainty Price/Fair Value Trailing Dividend Yield % Market Cap Investment Style Sector Industry None Extreme 0.4 — 74.7591 Mil Small Value Healthcare Drug Manufacturers - Specialty & Generic 0.01 20 5 10 Fair Value 0.56 Last Close 0.22 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities